About us:
In today’s world,
demand is rising rapidly. Healthcare needs are no exception, and are touching
new heights every day. Pharmaceutical companies – pillars of the healthcare
system – face multiple challenges of adhering to the imposed regulations,
providing affordable generics to patients and maintaining a diverse portfolio
with the constant pressure of the patent’s expiry. At Evertogen, we are
cognizant of these complexities and partner with clients in the face of stiff
challenges to help them achieve their objectives.
Taking complete
ownership, we develop, manufacture and market finished dosages for companies
around the world. With well-planned and equipped processes & systems in
place, we cater to the requirements of our clients in a timely and
cost-effective manner, bringing greater predictability to their business.
Evertogen’s journey
began with a single client in July 2013; today we are proud partners of nearly
twenty clients spread across the globe (Europe, USA, Canada, South Africa,
Australia, Ukraine & others). Our growth stems from our dynamism and the
promise of quality, accuracy, transparency & speed, with which we
relentlessly deliver to all our clients. With a flat organization structure in
place, each of our 230 employees has the freedom to communicate and function in
a fair & collaborative environment.
Our consistent
focus on meeting global regulatory standards has enabled us to successfully
attain regulatory approvals from the Ukrainian Health Authority, MHRA, EU MA,
Australia TGA and Health Canada. Our presence in the Special Economic Zone
(SEZ) enables us to offer competitive prices to our customers.
No comments:
Post a Comment